Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has completed its previously announced acquisition of Avedro, Inc. (Nasdaq: AVDR)
Read More
Magnolia Medical Technologies announced today a collaboration with Cardinal Health focused on improving clinical and economic outcomes by reducing blood culture contamination and false-positive diagnostic results for sepsis.
Read More
Venus Concept Inc., a global medical aesthetic technology leader today announced the completion of its previously announced merger with Restoration Robotic, Inc. (NASDAQ: HAIR, through November 7, 2019), a leader in robotic hair restoration, effective as of November 7, 2019. Following the completion of the merger, Venus Concept completed a $28 million equity financing by EW Healthcare Partners, HealthQuest Capital, SEDCO Capital and others.
Read More
HealthQuest leads a $100M financing to form Ajax III. The capital will target investing in companies in the areas of medtech, healthcare services, and healthcare IT that focus on truly innovative approaches to addressing major issues in healthcare. HealthQuest Capital led the funding, with participation from Polaris Partners.
Read More
Glaukos and Avedro announce definitive acquisition agreement under which Glaukos will acquire Avedro in an all-stock transaction
Read More
Castle Biosciences announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $16.00 per share.
Read More
Ajax Health announced today that it has raised an additional $15 million, closing out Ajax II at a total of more than $100 million.
Read More
Bardy Diagnostics, a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has recognized the Carnation Ambulatory Monitor (CAM™) with the "Best New Diagnostic Technology" award in the 2019 MedTech Breakthrough Awards program. Bardy Diagnostics earned the distinction for its innovative P-wave centric™ ambulatory cardiac patch monitoring and arrhythmia detection technology.
Read More
HealthQuest Capital, River Cities Capital Funds, Aperture Venture Partners, Aphelion Capital and others invested $35.M into BardyDx, a leading provider of ambulatory cardiac monitoring technologies and custom data solutions.
Read More
Ajax Health II, the latest medical device venture from serial healthcare entrepreneur Duke Rohlen, announced today that it has raised more than $85 million, which will be used to strategically operate and expand innovative medical device companies. HealthQuest Capital led the funding, with participation from Aisling Capital and Polaris Partners.
Read More
HealthQuest Capital has raised $440 million for its third fund, beating the $300 million target for its latest vehicle aimed at investing in growth-stage health-care companies.
Read More
HealthQuest Capital, a growth capital firm investing in companies that optimize value in healthcare, today announced the close of HealthQuest Partners III, L.P. at $440 million, oversubscribed and closed at the hard cap. Fund III will be invested in commercial-stage companies delivering innovation across all sectors of the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs.
Read More
Restoration Robotics (NASDAQ: HAIR), a global leader in robotic hair restoration, and Venus Concept, a privately-held global aesthetic technology leader, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
Read More
HealthQuest portfolio company Avedro, Inc. (Nasdaq: AVDR), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $14.00 per share, for total gross proceeds of $70.0 million.
Read More
Venus Concept announces the launch of its latest device, Venus Heal, which is now cleared in the U.S. to treat soft tissue injuries and conditions. Venus Heal is intended to relieve pain, improve blood circulation, and increase range of motion through the relief of muscle spasm.
Read More
Trice Medical announced that it is acquiring S.E.GWAY Orthopaedics (SegWAY), a leader in solutions for minimally invasive orthopedic procedures. SegWAY is best known for its Endoscopic Carpal Tunnel Release (ECTR), a device that supports minimally invasive carpal tunnel surgeries.
Read More
An article published in Arthroscopy: The Journal of Arthroscopic & Related Surgery further supports the benefits of HealthQuest portfolio company Trice’s Needle Arthroscopy. The results show Needle Arthroscopy is less costly and produces the same outcomes when compared to MRI.
Read More